1. Formulation Overview: Mechanisms of Niacinamide and Zinc PCA
The Ordinary Niacinamide 10% + Zinc 1% is a water-based serum engineered to regulate sebum secretion, reinforce epidermal integrity, and diminish cutaneous erythema through the combined actions of high-dose vitamin B3 and an essential mineral salt.
Niacinamide (nicotinamide) operates at the cellular level as a primary precursor to the coenzymes nicotinamide adenine dinucleotide (NAD+) and nicotinamide adenine dinucleotide phosphate (NADP+). These dinucleotides are fundamental electron carriers in cellular energy metabolism, driving enzymatic reactions necessary for keratinocyte proliferation, DNA repair, and lipid biosynthesis. In cutaneous biology, the topical supply of niacinamide accelerates de novo sphingolipid synthesis, notably boosting levels of epidermal ceramides, free fatty acids, and cholesterol within the stratum corneum. Concurrently, niacinamide suppresses the inflammatory cascade by inhibiting the release of pro-inflammatory cytokines—including interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-α)—and prevents melanosome transfer from melanocytes to neighboring keratinocytes via the protease-activated receptor 2 (PAR-2) pathway.
Zinc PCA (zinc salt of L-pyrrolidone carboxylic acid) provides a dual therapeutic mechanism. The PCA moiety serves as a physiologic humectant, mirroring components of the skin’s endogenous Natural Moisturizing Factor (NMF) to facilitate epidermal hydration. The zinc cation operates as a physiological astringent and antimicrobial agent that reduces the proliferation of Cutibacterium acnes. Crucially, zinc acts as a direct inhibitor of 5-alpha-reductase, the membrane-bound enzyme responsible for converting testosterone into dihydrotestosterone (DHT) within dermal sebocytes. By downregulating local DHT activity, Zinc PCA systematically suppresses sebaceous gland hyperactivity without inducing the structural dehydration commonly observed with alcohol-based astringents.
2. The 10% Concentration: Clinical Efficacy versus Barrier Tolerance
A critical divergence exists between dermatological literature and commercial formulation design regarding niacinamide concentrations. The landmark clinical trials that established the efficacy of topical niacinamide for barrier restoration, hyperpigmentation attenuation, and sebum regulation were conducted using concentrations ranging between 2% and 5%. At a 2% concentration, niacinamide demonstrably reduces transepidermal water loss (TEWL) and stimulates ceramide synthesis. At 4% to 5%, controlled comparative studies demonstrate parity with 1% clindamycin in managing inflammatory acne vulgaris, alongside visible reductions in photo-induced solar lentigines.
Formulating at a 10% threshold amplifies the active delivery gradient across the stratum corneum, which can expedite sebum normalization in thick, hyper-seborrheic skin phenotypes. However, supratherapeutic dosing introduces an elevated risk profile. Because topical absorption follows non-linear saturation kinetics, saturating the tissue with a 10% concentration frequently triggers adverse cutaneous reactions rather than proportionally accelerated results. The most common manifestation is transient facial erythema accompanied by stinging or pruritus.
This adverse reaction is occasionally mediated by trace residues of nicotinic acid (niacin), an industrial byproduct or hydrolytic breakdown derivative of niacinamide. Free nicotinic acid interacts directly with cutaneous G-protein-coupled receptors (specifically GPR109A), triggering immediate prostaglandin-mediated capillary vasodilation and perceptible flushing. Furthermore, applying an osmotic load of 10% pure solute onto an acutely compromised acid mantle can disrupt epidermal homeostasis, causing cellular irritation that patients frequently mistake for an acne “purging” event.
3. Formulation Chemistry: pH Windows and Base Viscosity
The chemical stability and biological availability of this formulation depend heavily on its aqueous vehicle and pH maintenance. The Ordinary Niacinamide 10% + Zinc 1% is buffered within a physiological pH range of 5.00 to 6.50. This parameter aligns closely with the acid mantle of human skin (typically pH 4.5 to 5.5), ensuring minimal disruption to resident microflora and enzymatic activities responsible for desquamation.
From a formulation perspective, maintaining the pH above 5.0 stabilizes the primary carboxamide group of the niacinamide molecule. If the formulation were to drift into strongly acidic environments (sub-pH 3.5) under prolonged thermal stress, acid-catalyzed hydrolysis could convert a fraction of the niacinamide into free nicotinic acid, drastically escalating the risk of cutaneous flushing. The buffering system utilized by the manufacturer prevents this hydrolytic conversion under standard shelf-life conditions.
The structural vehicle relies on water, pentylene glycol, dimethyl isosorbide, and hydroxyethylcellulose. Dimethyl isosorbide acts as a penetrant and solvent modifier, reducing active crystallization and facilitating dermal partitioning. Hydroxyethylcellulose functions as a non-ionic water-soluble polymer that produces the serum’s signature gel-like slip. However, this polymer base is notoriously prone to film-forming behavior. When layered beneath occlusive emollients or silicones before complete desiccation, or when rubbed with high shear stress, the polymeric matrix coagulates, resulting in noticeable cosmetic pilling.
4. Layering Order and Active Ingredient Interactions
Correct routine sequencing requires careful attention to viscosity, vehicle polarity, and chemical stability. As a low-to-medium viscosity water-based serum, the formulation must be positioned immediately following cleansing or liquid toners and strictly prior to anhydrous suspensions, lipid-dense emulsions, and occlusive creams. Applying this product over an oil or heavy cream creates a barrier that halts the transcellular diffusion of the hydrophilic niacinamide molecule.
Routine conflicts with this serum are widely misunderstood, particularly regarding L-ascorbic acid (pure vitamin C). Historical laboratory data from the 1960s demonstrated that niacinamide and ascorbic acid can form a yellow 1:1 molecular complex, leading to widespread claims that the two actives completely cancel each other out. In modern cosmetic chemistry, this complex formation is fully reversible at room temperature and represents minimal clinical concern on human skin. However, a legitimate physiological conflict remains: direct L-ascorbic acid requires a pH environment of 2.5 to 3.5 for optimum transdermal absorption. Layering a pH 5.5 to 6.5 serum directly over or under low-pH vitamin C elevates the total surface pH, neutralizing the penetrating capacity of the L-ascorbic acid and raising the potential for transient flushing.
To navigate these complex multi-step routines, analyzing formulation compatibility using Skin Scan Genius enables users to flag pH conflicts and stacked concentrations across their existing products. Outside of low-pH ascorbic acid, the serum interfaces exceptionally well with topical retinoids (such as adapalene, retinol, and tretinoin). By upregulating ceramide biosynthesis, niacinamide directly buffers against the barrier degradation, peeling, and erythema frequently provoked by retinization. When pairing with exfoliating direct acids (glycolic, lactic, or salicylic acids), clinicians advise temporal separation—using the exfoliating acid in the evening and the niacinamide formulation in the morning—to prevent additive barrier stress.
5. Clinical Application Protocol and Routine Design
To maximize clinical clearance of excess sebum while minimizing micro-inflammatory spikes, adherence to an empirical application protocol is advised:
- Patch Testing: Dispense two drops onto the inner surface of the forearm or behind the mastoid process once daily for 48 hours to screen for contact hypersensitivity.
- Frequency and Titration: Initiate usage once daily, preferably during the morning routine. Only advance to twice-daily application (morning and evening) after two weeks of demonstrated epidermal tolerance.
- Dosage Control: Two to three drops are sufficient to cover the entire face. Using excessive product does not elevate therapeutic saturation; it merely increases film thickness, elevating the likelihood of product pilling and localized stinging.
- Application Mechanics: Pat the serum gently across the cutaneous surface using clean fingertips until fully absorbed. Avoid vigorous, high-friction circular rubbing, which destabilizes the cellulosic gelling system. Allow 60 to 90 seconds of rest before applying succeeding emulsions or sunscreen.
If combining the serum with potent actives, evaluate the entire regimen carefully. Running individual product barcodes through the Skin Scan Genius database provides a personalized safety assessment, ensuring that high-strength zinc complexes do not overlap with other drying or astringent agents in your cabinet.
6. Target Indications and Safety Profile
This formulation is indicated for individuals presenting with seborrhea, superficial micro-comedones, enlarged follicular openings caused by sebaceous gland hypersecretion, and post-inflammatory erythema (PIE). Its non-comedogenic base makes it suitable for oily, combination, and acne-prone skin types that require barrier support without added lipid weight.
Conversely, patients presenting with a compromised epidermal barrier—characterized by ongoing stinging with neutral humectants, visible scaling, and active dermatitis—should avoid initiating a 10% niacinamide formulation. In these states, the high osmotic gradient and potential residual nicotinic acid frequently induce intense neurosensory stinging and vascular dilation. Patients with documented rosacea must proceed with caution; while low-dose niacinamide (2%) can strengthen vascular integrity in rosacea phenotypes, a 10% load can trigger marked facial flushing.
For clinical dermatological conditions including moderate-to-severe nodulocystic acne, chronic rosacea, atopic eczema, or recalcitrant melasma, non-prescription cosmetic serums are insufficient as standalone interventions. In these instances, patients must consult a board-certified dermatologist for a diagnosis and a medical-grade therapeutic regimen encompassing prescription retinoids, azelaic acid, or systemic agents.
Check it against your own routine. Skin Scan Genius reads a product’s full INCI list and flags conflicts with the actives you already use, by skin type and concern.
Frequently asked questions
Can The Ordinary Niacinamide 10% + Zinc 1% cause skin purging?
No, this serum does not cause true physiological purging. Purging occurs when an active ingredient accelerates the cellular turnover cycle of the epidermis (such as retinoids, AHAs, or BHAs), bringing microcomedones to the surface prematurely. If you develop new inflammatory papules, redness, or pustules with this serum, it reflects contact irritation, barrier disruption, or a vehicle reaction rather than cellular turnover.
Can I use this serum alongside salicylic acid (BHA)?
Yes, but they should be applied strategically to minimize barrier irritation. Because salicylic acid functions best at an acidic pH (3.0 to 4.0) and niacinamide is buffered around pH 5.5, apply salicylic acid first onto clean, dry skin. Allow it to absorb for a few minutes, then apply the niacinamide serum, or alternative usage between morning and evening routines.
Why does The Ordinary Niacinamide serum pill or flake off my skin?
Pilling is caused by the thick cellulose gelling agent (hydroxyethylcellulose) in the formula. If too much product is applied, if it is rubbed vigorously onto the skin, or if it is layered under heavy oils or silicone primers before drying completely, the polymer coagulates into visible white flakes. Using just 2 to 3 drops and pressing it gently onto the skin will resolve this issue.
Is a 10% concentration of niacinamide better than 5%?
Not necessarily. Most peer-reviewed clinical literature demonstrates that niacinamide provides optimal barrier repair, oil regulation, and pigment reduction at concentrations between 2% and 5%. Raising the concentration to 10% offers a more intense direct delivery gradient for hyper-seborrheic skin, but it significantly elevates the incidence of contact irritation, flushing, and redness without providing double the clinical benefit.
